ORGANON & CO (OGN) Fundamental Analysis & Valuation

NYSE:OGN • US68622V1061

Current stock price

5.84 USD
-0.21 (-3.47%)
At close:
5.9 USD
+0.06 (+1.03%)
After Hours:

This OGN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. OGN Profitability Analysis

1.1 Basic Checks

  • OGN had positive earnings in the past year.
  • In the past year OGN had a positive cash flow from operations.
  • In the past 5 years OGN has always been profitable.
  • Each year in the past 5 years OGN had a positive operating cash flow.
OGN Yearly Net Income VS EBIT VS OCF VS FCFOGN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • OGN has a better Return On Assets (1.45%) than 81.87% of its industry peers.
  • OGN's Return On Equity of 24.87% is amongst the best of the industry. OGN outperforms 93.26% of its industry peers.
  • OGN has a Return On Invested Capital of 10.22%. This is amongst the best in the industry. OGN outperforms 89.64% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for OGN is below the industry average of 13.06%.
Industry RankSector Rank
ROA 1.45%
ROE 24.87%
ROIC 10.22%
ROA(3y)5.51%
ROA(5y)7.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.88%
ROIC(5y)13.46%
OGN Yearly ROA, ROE, ROICOGN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K

1.3 Margins

  • OGN has a better Profit Margin (3.01%) than 81.87% of its industry peers.
  • OGN's Profit Margin has declined in the last couple of years.
  • OGN has a Operating Margin of 21.81%. This is amongst the best in the industry. OGN outperforms 88.60% of its industry peers.
  • OGN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of OGN (53.30%) is better than 67.36% of its industry peers.
  • In the last couple of years the Gross Margin of OGN has declined.
Industry RankSector Rank
OM 21.81%
PM (TTM) 3.01%
GM 53.3%
OM growth 3Y-8.43%
OM growth 5Y-13.12%
PM growth 3Y-41.27%
PM growth 5Y-38.09%
GM growth 3Y-5.75%
GM growth 5Y-4.63%
OGN Yearly Profit, Operating, Gross MarginsOGN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. OGN Health Analysis

2.1 Basic Checks

  • OGN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, OGN has more shares outstanding
  • OGN has more shares outstanding than it did 5 years ago.
  • OGN has a better debt/assets ratio than last year.
OGN Yearly Shares OutstandingOGN Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
OGN Yearly Total Debt VS Total AssetsOGN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • Based on the Altman-Z score of 1.21, we must say that OGN is in the distress zone and has some risk of bankruptcy.
  • OGN has a Altman-Z score (1.21) which is comparable to the rest of the industry.
  • OGN has a debt to FCF ratio of 22.51. This is a negative value and a sign of low solvency as OGN would need 22.51 years to pay back of all of its debts.
  • OGN has a better Debt to FCF ratio (22.51) than 75.65% of its industry peers.
  • OGN has a Debt/Equity ratio of 11.47. This is a high value indicating a heavy dependency on external financing.
  • OGN has a worse Debt to Equity ratio (11.47) than 81.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 11.47
Debt/FCF 22.51
Altman-Z 1.21
ROIC/WACC1.72
WACC5.93%
OGN Yearly LT Debt VS Equity VS FCFOGN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 1.82 indicates that OGN should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.82, OGN is doing worse than 64.25% of the companies in the same industry.
  • OGN has a Quick Ratio of 1.23. This is a normal value and indicates that OGN is financially healthy and should not expect problems in meeting its short term obligations.
  • OGN has a worse Quick ratio (1.23) than 69.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.23
OGN Yearly Current Assets VS Current LiabilitesOGN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. OGN Growth Analysis

3.1 Past

  • The earnings per share for OGN have decreased strongly by -10.95% in the last year.
  • Measured over the past years, OGN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -39.06% on average per year.
  • Looking at the last year, OGN shows a decrease in Revenue. The Revenue has decreased by -2.92% in the last year.
  • OGN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.99% yearly.
EPS 1Y (TTM)-10.95%
EPS 3Y-10.06%
EPS 5Y-39.06%
EPS Q2Q%-30%
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y0.23%
Revenue growth 5Y-0.99%
Sales Q2Q%-5.34%

3.2 Future

  • Based on estimates for the next years, OGN will show a small growth in Earnings Per Share. The EPS will grow by 1.48% on average per year.
  • Based on estimates for the next years, OGN will show a small growth in Revenue. The Revenue will grow by 0.88% on average per year.
EPS Next Y-4.34%
EPS Next 2Y1.31%
EPS Next 3Y4.81%
EPS Next 5Y1.48%
Revenue Next Year-0.73%
Revenue Next 2Y0.46%
Revenue Next 3Y0.66%
Revenue Next 5Y0.88%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OGN Yearly Revenue VS EstimatesOGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
OGN Yearly EPS VS EstimatesOGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

8

4. OGN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 1.60, which indicates a rather cheap valuation of OGN.
  • Compared to the rest of the industry, the Price/Earnings ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 98.45% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 24.88. OGN is valued rather cheaply when compared to this.
  • OGN is valuated cheaply with a Price/Forward Earnings ratio of 1.67.
  • Based on the Price/Forward Earnings ratio, OGN is valued cheaper than 98.45% of the companies in the same industry.
  • OGN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 1.6
Fwd PE 1.67
OGN Price Earnings VS Forward Price EarningsOGN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OGN indicates a rather cheap valuation: OGN is cheaper than 95.85% of the companies listed in the same industry.
  • 96.89% of the companies in the same industry are more expensive than OGN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.96
EV/EBITDA 5.62
OGN Per share dataOGN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

  • OGN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.31%
EPS Next 3Y4.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. OGN Dividend Analysis

5.1 Amount

  • OGN has a Yearly Dividend Yield of 1.32%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.79, OGN pays a better dividend. On top of this OGN pays more dividend than 90.67% of the companies listed in the same industry.
  • Compared to the average S&P500 Dividend Yield of 1.90, OGN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.32%

5.2 History

  • OGN has been paying a dividend for over 5 years, so it has already some track record.
  • OGN has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
OGN Yearly Dividends per shareOGN Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • OGN pays out 47.06% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP47.06%
EPS Next 2Y1.31%
EPS Next 3Y4.81%
OGN Yearly Income VS Free CF VS DividendOGN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
OGN Dividend Payout.OGN Dividend Payout, showing the Payout Ratio.OGN Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

OGN Fundamentals: All Metrics, Ratios and Statistics

ORGANON & CO

NYSE:OGN (3/27/2026, 8:04:00 PM)

After market: 5.9 +0.06 (+1.03%)

5.84

-0.21 (-3.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-12
Earnings (Next)04-29
Inst Owners77.83%
Inst Owner Change-1.31%
Ins Owners0.36%
Ins Owner Change12.68%
Market Cap1.52B
Revenue(TTM)6.22B
Net Income(TTM)187.00M
Analysts48.75
Price Target9.18 (57.19%)
Short Float %6.28%
Short Ratio3.11
Dividend
Industry RankSector Rank
Dividend Yield 1.32%
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP47.06%
Div Incr Years0
Div Non Decr Years3
Ex-Date02-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3.71%
Min EPS beat(2)-14.22%
Max EPS beat(2)6.8%
EPS beat(4)3
Avg EPS beat(4)2.37%
Min EPS beat(4)-14.22%
Max EPS beat(4)12.44%
EPS beat(8)6
Avg EPS beat(8)4.4%
EPS beat(12)8
Avg EPS beat(12)3.56%
EPS beat(16)11
Avg EPS beat(16)5.27%
Revenue beat(2)1
Avg Revenue beat(2)-1.2%
Min Revenue beat(2)-3.09%
Max Revenue beat(2)0.69%
Revenue beat(4)2
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)1.72%
Revenue beat(8)4
Avg Revenue beat(8)-0.29%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)9
Avg Revenue beat(16)-0.15%
PT rev (1m)-3.82%
PT rev (3m)-6.9%
EPS NQ rev (1m)-7.87%
EPS NQ rev (3m)-17.52%
EPS NY rev (1m)-9.63%
EPS NY rev (3m)-11.81%
Revenue NQ rev (1m)0.2%
Revenue NQ rev (3m)-1.11%
Revenue NY rev (1m)1.07%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 1.6
Fwd PE 1.67
P/S 0.24
P/FCF 3.96
P/OCF 2.17
P/B 2.02
P/tB N/A
EV/EBITDA 5.62
EPS(TTM)3.66
EY62.67%
EPS(NY)3.5
Fwd EY59.95%
FCF(TTM)1.48
FCFY25.26%
OCF(TTM)2.69
OCFY46.04%
SpS23.88
BVpS2.89
TBVpS-17.41
PEG (NY)N/A
PEG (5Y)N/A
Graham Number15.42
Profitability
Industry RankSector Rank
ROA 1.45%
ROE 24.87%
ROCE 12.94%
ROIC 10.22%
ROICexc 10.82%
ROICexgc 23.19%
OM 21.81%
PM (TTM) 3.01%
GM 53.3%
FCFM 6.18%
ROA(3y)5.51%
ROA(5y)7.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)10.88%
ROIC(5y)13.46%
ROICexc(3y)11.64%
ROICexc(5y)14.58%
ROICexgc(3y)28.78%
ROICexgc(5y)42.53%
ROCE(3y)13.77%
ROCE(5y)17.04%
ROICexgc growth 3Y-25.36%
ROICexgc growth 5Y-17.91%
ROICexc growth 3Y-15.47%
ROICexc growth 5Y-16.06%
OM growth 3Y-8.43%
OM growth 5Y-13.12%
PM growth 3Y-41.27%
PM growth 5Y-38.09%
GM growth 3Y-5.75%
GM growth 5Y-4.63%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 11.47
Debt/FCF 22.51
Debt/EBITDA 5.03
Cap/Depr 87.53%
Cap/Sales 5.08%
Interest Coverage 2.93
Cash Conversion 40.77%
Profit Quality 205.35%
Current Ratio 1.82
Quick Ratio 1.23
Altman-Z 1.21
F-Score5
WACC5.93%
ROIC/WACC1.72
Cap/Depr(3y)108.28%
Cap/Depr(5y)123.91%
Cap/Sales(3y)4.91%
Cap/Sales(5y)4.87%
Profit Quality(3y)108.67%
Profit Quality(5y)109.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-10.95%
EPS 3Y-10.06%
EPS 5Y-39.06%
EPS Q2Q%-30%
EPS Next Y-4.34%
EPS Next 2Y1.31%
EPS Next 3Y4.81%
EPS Next 5Y1.48%
Revenue 1Y (TTM)-2.92%
Revenue growth 3Y0.23%
Revenue growth 5Y-0.99%
Sales Q2Q%-5.34%
Revenue Next Year-0.73%
Revenue Next 2Y0.46%
Revenue Next 3Y0.66%
Revenue Next 5Y0.88%
EBIT growth 1Y-7.44%
EBIT growth 3Y-8.23%
EBIT growth 5Y-13.98%
EBIT Next Year11.97%
EBIT Next 3Y6.45%
EBIT Next 5Y7.02%
FCF growth 1Y-34.69%
FCF growth 3Y-11.55%
FCF growth 5Y-27.61%
OCF growth 1Y-25.45%
OCF growth 3Y-6.56%
OCF growth 5Y-20.37%

ORGANON & CO / OGN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ORGANON & CO?

ChartMill assigns a fundamental rating of 5 / 10 to OGN.


What is the valuation status of ORGANON & CO (OGN) stock?

ChartMill assigns a valuation rating of 8 / 10 to ORGANON & CO (OGN). This can be considered as Undervalued.


What is the profitability of OGN stock?

ORGANON & CO (OGN) has a profitability rating of 7 / 10.


What is the valuation of ORGANON & CO based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ORGANON & CO (OGN) is 1.6 and the Price/Book (PB) ratio is 2.02.


What is the expected EPS growth for ORGANON & CO (OGN) stock?

The Earnings per Share (EPS) of ORGANON & CO (OGN) is expected to decline by -4.34% in the next year.